Logo
x

Search

Subscribe Now

approvalFDA

Pfizer's Panzyga Receives the US FDA's Approval of sBLA for Chronic Inflammatory Demyelinating Polyneuropathy

Pfizer's Panzyga Receives the US FDA's Approval of sBLA for Chronic Inflammatory Demyelinating Polyneuropathy

  • February 15, 2021
Aurinia Lupkynis (voclosporin) Receives US FDA's Approval to Treat Adult Patients with Active Lupus Nephritis

Aurinia Lupkynis (voclosporin) Receives US FDA's Approval to Treat Adult Patients with Active Lupus Nephritis

  • January 25, 2021
Ultragenyx and Kyowa Kirin's Crysvita (burosumab) Receive the US FDA's Approval for the Treatment of Tumor-Induced Osteomalacia

Ultragenyx and Kyowa Kirin's Crysvita (burosumab) Receive the US FDA's Approval for the Treatment of Tumor-Induced Osteomalacia

  • June 19, 2020
Eli Lilly's Taltz (ixekizumab) Receives the US FDA's Approval for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis

Eli Lilly's Taltz (ixekizumab) Receives the US FDA's Approval for the Treatment of Pediatric Patients with Moderate to Severe Plaq...

  • March 30, 2020
Roche's Rozlytrek (entrectinib) Receives the US FDA Approval for ROS1-Positive Metastatic Non-Small Cell Lung Cancer and NTRK Gene Fusion-Positive Solid Tumors

Roche's Rozlytrek (entrectinib) Receives the US FDA Approval for ROS1-Positive Metastatic Non-Small Cell Lung Cancer and NTRK Gene...

  • August 16, 2019
Pfizer's Ruxience (biosimilar- rituximab) Receives FDA's Approval for Cancer and Autoimmune Diseases

Pfizer's Ruxience (biosimilar- rituximab) Receives FDA's Approval for Cancer and Autoimmune Diseases

  • July 24, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.